ODC1 and neuroblastoma: Overall, these data are in contrast with the neuroblastoma results and suggest a unique biology for this MYCN-driven pediatric malignancy where the AA genotype predicts a better outcome and where high ODC1 expression is consistently associated with poor outcome.